LifePlan Financial Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $4K | Hold |
1,440
| – | – | ﹤0.01% | 505 |
|
|
2020
Q2 | $6K | Hold |
1,440
| – | – | ﹤0.01% | 467 |
|
|
2020
Q1 | $1K | Hold |
1,440
| – | – | ﹤0.01% | 545 |
|
|
2019
Q4 | $2K | Hold |
1,440
| – | – | ﹤0.01% | 520 |
|
|
2019
Q3 | $1K | Hold |
1,440
| – | – | ﹤0.01% | 544 |
|
|
2019
Q2 | $1K | Sell |
1,440
-1
| -0.1% | -$1 | ﹤0.01% | 541 |
|
|
2019
Q1 | $4K | Hold |
1,441
| – | – | ﹤0.01% | 483 |
|
|
2018
Q4 | $3K | Hold |
1,441
| – | – | ﹤0.01% | 489 |
|
|
2018
Q3 | $7K | Hold |
1,441
| – | – | ﹤0.01% | 425 |
|
|
2018
Q2 | $7K | Hold |
1,441
| – | – | ﹤0.01% | 411 |
|
|
2018
Q1 | $10K | Hold |
1,441
| – | – | 0.01% | 372 |
|
|
2017
Q4 | $12K | Hold |
1,441
| – | – | 0.01% | 109 |
|
|
2017
Q3 | $12K | Hold |
1,441
| – | – | 0.01% | 109 |
|
|
2017
Q2 | $15K | Hold |
1,441
| – | – | 0.01% | 107 |
|
|
2017
Q1 | $17K | Hold |
1,441
| – | – | 0.01% | 109 |
|
|
2016
Q4 | $18K | Hold |
1,441
| – | – | 0.01% | 115 |
|
|
2016
Q3 | $26K | Hold |
1,441
| – | – | 0.02% | 109 |
|
|
2016
Q2 | $15K | Hold |
1,441
| – | – | 0.01% | 99 |
|
|
2016
Q1 | $27K | Hold |
1,441
| – | – | 0.02% | 97 |
|
|
2015
Q4 | $38K | Hold |
1,441
| – | – | 0.03% | 90 |
|
|
2015
Q3 | $66K | Hold |
1,441
| – | – | 0.05% | 87 |
|
|
2015
Q2 | $46K | Hold |
1,441
| – | – | 0.03% | 94 |
|
|
2015
Q1 | $46K | Hold |
1,441
| – | – | 0.03% | 78 |
|
|
2014
Q4 | $54K | Hold |
1,441
| – | – | 0.04% | 81 |
|
|
2014
Q3 | $38K | Hold |
1,441
| – | – | 0.03% | 68 |
|
|
2014
Q2 | $43K | Hold |
1,441
| – | – | 0.03% | 65 |
|
|
2014
Q1 | $53K | Hold |
1,441
| – | – | 0.04% | 116 |
|
|
2013
Q4 | $60K | Hold |
1,441
| – | – | 0.04% | 106 |
|
|
2013
Q3 | $76K | Hold |
1,441
| – | – | 0.06% | 82 |
|
|
2013
Q2 | $77K | Buy |
+1,441
| New | +$77K | 0.09% | 62 |
|